Qiagen has agreed to buy Canada's Nextal Biotechnology for up to $14.2 million, with $9.7 million in cash and the rest paid out according to predetermined milestones. Nextal has developed products that "simplify the process of sample preparation of proteins for subsequent crystallographic analysis."
- read this press release for more